• Inflammation sets off sensory alarms

    Monday September 7th 2020

  • BioLizard expands services in Switzerland with appointment of Per Rigler as Business Development Manager

    Wednesday September 2nd 2020

  • Promethera® announces changes in executive leadership

    Wednesday September 2nd 2020

  • Rewind Therapeutics appoints biopharmaceutical industry veteran Kees Been as Non-Executive Director

    Wednesday September 2nd 2020

  • FOx Biosystems appoints new CEO

    Tuesday September 1st 2020

  • Biocartis expands collaboration with LifeArc

    Tuesday September 1st 2020

  • Oxurion NV reports first patient dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)

    Tuesday September 1st 2020

  • V-Bio Ventures invests in Biodol Therapeutics

    Monday August 31st 2020

  • Your news here?

  • Newton Biocapital I invests in J-Pharma Co., Ltd. in Japan focusing on drug development targeting L-type Amino Acid Transporter 1 (LAT1) for cancer and autoimmune diseases

    Thursday August 27th 2020

  • Vlaanderen investeert ruim kwart miljoen euro in Belgische Google van de genetica

    Wednesday August 26th 2020

  • Persomed appoints Kristof Vercruysse as CEO to drive personalized cancer vaccine venture’s successful implementation

    Monday August 24th 2020


Strategic Partners